The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
70 - 100 jobs Number of planned job losses
Announcement Date
2 May 2007
Employment effect (start)
31 May 2007
Foreseen end date
31 December 2010
Description
On 2 May 2007 the British-Swedish pharmaceutical company AstraZeneca announced its plans to cut between 70 and 100 jobs out of 235 manufacturing jobs in France. The planned job reductions will take place between May 2007 and December 2010. These job losses in France are part of the worldwide restructuring announced by AstraZeneca in February 2007 and embedded in cost-saving plans to secure future investments and acquisitions.
Sources
2 May 2007: Les Echos
Citation
Eurofound (2007), Astra Zeneca, Internal restructuring in France, factsheet number 65299, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/65299.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
